Direct Injection Broadcasting – Who Is Communicating To The Public?

The European Court of Justice (ECJ) has ruled that a broadcaster is not making a communication to the public for the purposes of Article 3(1) of the Copyright Directive (2001/29/EC) (Article 3(1)) when it transmits programme-carrying signals to its signal distributors (and not to any wider public) during the two-stage process known as direct injection broadcasting. A broadcaster does not therefore require the consent of the copyright owner for these purposes nor are they liable for any royalty payments for such delivery of the signal to its distributors. Instead, as a matter of law, the distributors are responsible for obtaining these rights and covering the associated royalties since they make the communication to the public.

What is direct injection broadcasting?

Direct injection broadcasting is a two-stage process by which a broadcaster transmits to its distributors programme-carrying signals via a "point to point" private line. The distributors pick up this signal and pass it on to subscribers who are then able to view the programmes on their televisions.

Facts of the case

In the case in question (SBS Belgium NV v. Belgische Vereniging van Auteurs, Componisten en Uitgevers (SABAM), case C-325/14, 19 November 2015), copyright administration society, SABAM, required Dutch language broadcaster, SBS, to pay almost €1 million in copyright fees. SABAM considered that the authorisation of copyright holders was required for SBS's transmission of signal using the direct injection method and therefore this royalty amount was due.

The relevant court in Brussels, rechtbank van koophandel te Brussel, referred the following question to the ECJ:

"Does a broadcasting organisation which transmits its programmes exclusively via the technique of direct injection ... make a communication to the public within the meaning of Article 3 of Directive 2001/29?" (SBS Belgium NV v. Belgische Vereniging van Auteurs, Componisten en Uitgevers (SABAM), case...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT